Alhambra Investment Partners LLC Eli Lilly & CO Transaction History

Alhambra Investment Partners LLC

$206 Million
Q3 2025

A detailed history of Alhambra Investment Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alhambra Investment Partners LLC holds 1,158 shares of LLY stock, worth $948,842. This represents 0.43% of its overall portfolio holdings.

Number of Shares

1,158

Previous 924 25.32%

Holding current value

$948,842

Previous $720,000 22.64%

% of portfolio

0.43%

Previous 0.36%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$625.65 - $812.69 $146,402 - $190,169	234 Added 25.32%	1,158 $883,000
Q2 2025 Jul 15, 2025	BUY	$713.71 - $898.95 $317,600 - $400,032	445 Added 92.9%	924 $720,000
Q1 2025 Apr 15, 2025	BUY	$725.72 - $929.72 $10,160 - $13,016	14 Added 3.01%	479 $395,000
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $38,607 - $48,001	-50 Reduced 9.71%	465 $411,000
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $11,844 - $15,845	-20 Reduced 3.74%	515 $400,000
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $26,259 - $30,956	-50 Reduced 8.55%	535 $311,000
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $4,347 - $5,993	-10 Reduced 1.68%	585 $314,000
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $208,690 - $279,043	595 New	595 $279,000
Q1 2021 Apr 16, 2021	SELL	$164.32 - $212.72 $212,630 - $275,259	-1,294 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $168,815 - $223,383	1,294 New	1,294 $218,000
Q3 2020 Nov 17, 2020	SELL	$146.22 - $169.13 $186,284 - $215,471	-1,274 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $173,799 - $209,165	1,274 New	1,274 $209,000

Others Institutions Holding LLY

# of Institutions

4,453

Shares Held

780M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alhambra Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alhambra Investment Partners LLC with notifications on news.

Account

Alhambra Investment Partners LLC Eli Lilly & CO Transaction History